Position in LLY
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$35,299,227
+$8,854,000 QoQ
Shares Held
29,430
+2.4% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
2.11%
of 13F equity value
Holder Rank
#648
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MONTAG A & ASSOCIATES INC holds $100,006,894 across 14 Drug Manufacturers - General names. LLY ranks #1 (35.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
29,430 | $35,299,227 | |
| 2 | JNJ |
Johnson & Johnson
|
89,578 | $22,750,124 | |
| 3 | ABBV |
AbbVie Inc.
|
72,344 | $18,204,644 | |
| 4 | MRK |
Merck & Co., Inc.
|
136,408 | $17,528,428 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
37,785 | $2,177,171 | |
| 6 | NVS |
Novartis AG
|
7,847 | $1,229,781 | |
| 7 | PFE |
Pfizer Inc
|
50,191 | $1,208,599 | |
| 8 | AMGN |
Amgen Inc
|
2,744 | $993,657 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $35,299,227 | 29,430 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $26,445,227 | 28,752 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $30,315,650 | 28,209 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $17,017,189 | 22,303 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $17,647,000 | 22,638 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $18,931,509 | 22,922 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $18,138,140 | 23,495 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $25,350,287 | 28,614 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $24,763,048 | 27,351 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $21,600,837 | 27,766 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $16,911,092 | 29,011 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $16,037,627 | 29,858 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $14,277,627 | 30,444 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $11,789,952 | 34,331 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $14,073,498 | 38,469 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $12,923,006 | 39,966 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $13,233,771 | 40,816 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $11,821,067 | 41,279 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $11,457,881 | 41,481 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $6,275,549 | 27,161 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $6,326,718 | 27,565 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $5,415,911 | 28,990 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $4,889,099 | 28,957 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $4,287,843 | 28,968 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $4,788,802 | 29,168 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $4,060,056 | 29,268 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||